Mad at NICE's cancer drug rejections? Look to drugmakers, agency chief says | Pharmaguy's Insights Into Drug Industry News |
Political shilly-shallying about the cost of drugs has to end, the chief of the U.K.'s cost-effectiveness agency says. Government officials and politicians need to be up front with the public about one stark fact: The country's health service just can't afford every drug that can help patients.

The NHS isn't "a bottomless pit," he told the Financial Times.

And as for the patient advocates and public health organizations decrying those choices? They need to think about pointing fingers elsewhere, Dillon said. If drugmakers priced their drugs more reasonably, they might win NICE backing.